Document is current
Any future updates will be listed below
-
Authors
Zanni, Louise https://orcid.org/0009-0005-7696-2307
Journiac, Jonathan https://orcid.org/0000-0003-1229-8329
Savard, Josée https://orcid.org/0000-0002-8052-1046
Guerdoux, Estelle https://orcid.org/0000-0002-9608-0791
Paillard-Brunet, Guilhem
Fasse, Léonor https://orcid.org/0000-0003-1365-0566
Le Provost, Jean-Bernard
Charles, Cécile https://orcid.org/0000-0003-3126-1337
Dauchy, Sarah https://orcid.org/0000-0001-6220-5624
Boinon, Diane https://orcid.org/0000-0002-8963-0847
-
Funding
Funding for this research was provided by:
National Cancer Institute (INCa SHS 2020 n°2020-1-PL SHS-03-IGR-1)
National Cancer Institute (INCa SHS 2020 n°2020-1-PL SHS-03-IGR-1)
National Cancer Institute (INCa SHS 2020 n°2020-1-PL SHS-03-IGR-1)
National Cancer Institute (INCa SHS 2020 n°2020-1-PL SHS-03-IGR-1)
National Cancer Institute (INCa SHS 2020 n°2020-1-PL SHS-03-IGR-1)
- License Information
-
More Information
Article History
Received: 24 July 2024
Accepted: 17 February 2025
First Online: 28 February 2025
Declarations
:
: This study was approved by the French regulatory and ethics authorities (Comité de Protection des Personnes Sud-Méditerranée II—N° ID RCB: 2021-A01891-40) in accordance with European regulations, Guideline for Good Clinical Practice (GCP), and the ethical principles that have their origins in the Declaration of Helsinki.
: All participants received oral and written information about the purpose and the procedures of the study, before giving their oral consent to participate in this study.
: We confirm that the manuscript has been read and approved for submission by all authors and that all persons listed as authors have contributed to preparing the manuscript and that no persons other than the authors listed have contributed significantly to its preparation.
: The authors declare no competing interests.
